Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 69 results
Author
Title
Type
Year
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
P
Pauli C
,
Puca L
,
Mosquera JMiguel
,
Robinson BD
,
Beltran H
,
Rubin MA
,
Rao RA
. 2016.
An emerging role for cytopathology in precision oncology.
.
Cancer Cytopathol. 124(3):167-73.
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Prandi D
,
Baca SC
,
Romanel A
,
Barbieri CE
,
Mosquera J-M
,
Fontugne J
,
Beltran H
,
Sboner A
,
Garraway LA
,
Rubin MA
et al.
. 2014.
Unraveling the clonal hierarchy of somatic genomic aberrations.
.
Genome Biol. 15(8):439.
Pritchard CC
,
Mateo J
,
Walsh MF
,
De Sarkar N
,
Abida W
,
Beltran H
,
Garofalo A
,
Gulati R
,
Carreira S
,
Eeles R
et al.
. 2016.
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
.
N Engl J Med. 375(5):443-53.
Puca L
,
Vlachostergios PJ
,
Beltran H
. 2018.
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies.
.
Cold Spring Harb Perspect Med.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
R
Ramnarine VRohan
,
Alshalalfa M
,
Mo F
,
Nabavi N
,
Erho N
,
Takhar M
,
Shukin R
,
Brahmbhatt S
,
Gawronski A
,
Kobelev M
et al.
. 2018.
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications.
.
Gigascience.
Rickman DS
,
Beltran H
,
Demichelis F
,
Rubin MA
. 2017.
Biology and evolution of poorly differentiated neuroendocrine tumors.
.
Nat Med. 23(6):1-10.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
S
Sailer V
,
Pauli C
,
Merzier EC
,
Mosquera JMiguel
,
Beltran H
,
Rubin MA
,
Rao RA
. 2017.
On-site Cytology for Development of Patient-Derived Three-dimensional Organoid Cultures - A Pilot Study.
.
Anticancer Res. 37(4):1569-1573.
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2017.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer.
Shukla S
,
Cyrta J
,
Murphy DA
,
Walczak EG
,
Ran L
,
Agrawal P
,
Xie Y
,
Chen Y
,
Wang S
,
Zhan Y
et al.
. 2017.
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance.
.
Cancer Cell. 32(6):792-806.e7.
Sternberg CN
,
Beltran H
. 2017.
Prostate cancer in 2016: Improved outcomes and precision medicine come within reach.
.
Nat Rev Urol. 14(2):71-72.
T
Tagawa ST
,
Beltran H
. 2011.
Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer.
.
Asian J Androl. 13(6):785-6.
Terry S
,
Maillé P
,
Baaddi H
,
Kheuang L
,
Soyeux P
,
Nicolaiew N
,
Ceraline J
,
Firlej V
,
Beltran H
,
Allory Y
et al.
. 2013.
Cross modulation between the androgen receptor axis and protocadherin-PC in mediating neuroendocrine transdifferentiation and therapeutic resistance of prostate cancer.
.
Neoplasia. 15(7):761-72.
Terry S
,
Beltran H
. 2014.
The many faces of neuroendocrine differentiation in prostate cancer progression.
.
Front Oncol. 4:60.
Terry S
,
El-Sayed IY
,
Destouches D
,
Maillé P
,
Nicolaiew N
,
Ploussard G
,
Semprez F
,
Pimpie C
,
Beltran H
,
Londono-Vallejo A
et al.
. 2015.
CRIPTO overexpression promotes mesenchymal differentiation in prostate carcinoma cells through parallel regulation of AKT and FGFR activities.
.
Oncotarget. 6(14):11994-2008.
W
Wilkes DC
,
Sailer V
,
Xue H
,
Cheng H
,
Collins CC
,
Gleave M
,
Wang Y
,
Demichelis F
,
Beltran H
,
Rubin MA
et al.
. 2017.
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.
.
Cold Spring Harb Mol Case Stud. 3(5)
« first
‹ previous
1
2
3
(current)